Bardin Hill Management Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-62,790
Closed -$3.24M 112
2022
Q3
$3.24M Buy
+62,790
New +$2.6M 0.75% 32

Other funds holding CCXI

Bardin Hill Management Partners's CCXI Position: Q4 2022 in Review

Bardin Hill Management Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 62,790 shares — an estimated $3.24M sold.

Bardin Hill Management Partners first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $3.24M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Bardin Hill Management Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Bardin Hill Management Partners sold 62,790 ChemoCentryx, Inc. shares in Q4 2022, an estimated $3.24M.
  • Bardin Hill Management Partners first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
  • Bardin Hill Management Partners's ChemoCentryx, Inc. position peaked at $3.24M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Bardin Hill Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.